Showing all 3 results
Glibenclamide, Metformin & Pioglitazone Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, High-Density Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips to ensure the absolute chemical stability of the three highly reactive APIs.
Active Ingredient Strength Primary Clinical Function Glibenclamide USP/Ph.Eur. 5 mg The Secretagogue (Micro-Dose): Triggers rapid, potent insulin release from the pancreas to control acute post-prandial (after-meal) glucose spikes. Pioglitazone (as Hydrochloride) USP/Ph.Eur. 15 mg The Sensitizer (Micro-Dose): Reverses deep cellular insulin resistance in skeletal muscle and adipose tissue. Metformin Hydrochloride USP/Ph.Eur. 500 mg (IR or ER) The Hepatic Anchor (Macro-Dose): Provides baseline suppression of liver glucose production. Frequently formulated in a sustained-release matrix to minimize severe GI side effects. Excipients Microcrystalline Cellulose / Croscarmellose Sodium / Hypromellose / Magnesium Stearate / Premium Opadry Film Diluent / Superdisintegrant / Binder (ER Polymer) / Lubricant (Engineered utilizing elite multi-stage geometric dilution to guarantee that the lethal 5mg micro-dose of Glibenclamide is flawlessly and evenly distributed throughout the massive 500mg Metformin matrix) *Pack Sizes: 10×10 Alu-Alu Blisters (Optimized specifically for strict, chronic diabetic dispensing regimens).
Vildagliptin & Metformin Tablets
FreeProduct Composition & Strength
We supply this product as a highly advanced Film-Coated Tablet (Available in Immediate or Bilayer Sustained-Release formats), packed strictly in high-barrier Alu-Alu blister strips. Alu-Alu packaging is completely non-negotiable, as Vildagliptin is intensely sensitive to moisture degradation.
Active Ingredient Strength & Format Primary Clinical Use Vildagliptin INN/Ph.Eur. 50 mg (Immediate Release Layer) Rapid dissolution to block DPP-4 and manage post-prandial incretin levels. Metformin Hydrochloride USP/BP 500 mg / 850 mg / 1000 mg (IR or SR) Provides continuous baseline hepatic glucose suppression and peripheral sensitization. Excipients Hypromellose (HPMC) / Microcrystalline Cellulose / Titanium Dioxide SR Polymer Matrix / Diluent / Film-Coating (Engineered for precise kinetic release) Vildagliptin Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended Uncoated or Film-Coated Tablet, packed strictly in high-barrier Alu-Alu blister strips to guarantee absolute protection from moisture and environmental degradation.
Active Ingredient Strength Primary Clinical Use Vildagliptin INN/Ph.Eur. 50 mg Standard Adult Dose for monotherapy or adjunctive combination therapy. Excipients Microcrystalline Cellulose / Anhydrous Lactose / Magnesium Stearate Diluent / Lubricant (Engineered for optimal compressibility and rapid gastric dispersion)
